Spanish law

New Spanish patent law 24/2015 

Main changes introduced by the new law

Studies and clinical testing directed to obtain the market authorization in Spain or abroad do not infringe the patent rights. This includes preparing, obtaining and using of the relevant active ingredient.

→   Shift to a granting system with substantive examination and post-grant opposition, for all Spanish patent applications →   Obligation of first filing a European or PCT application at the SPTO, for inventions made in Spain →   Possibility of limiting the scope of protection after grant/opposition →   Utility models →   Priority right →   Patentability →   Non-prejudicial disclosures →   Employees’ inventions →   Supplementary Protection Certificates and their procedure →   Bolar Provision →   Official fees and renewals →   Rehabilitation and restoration of rights →   Nullity →   Protective letters →   Compulsory licenses →   Jurisdiction and procedural provisions

Recent tweets

Montserrat Jané shares knowledge as part of 2022 patents course organised by the SPTO and the Patent Centre of the UB zbm-patents.eu/en/montserrat-… pic.twitter.com/MUVvKMUTsY

Last week from ZBM Patents's Twitter via Twitter Web App

Main office

Rambla de Catalunya, 123

08008 Barcelona

T +34 933 426 472

Madrid

C/ Orense, 12

2nd Floor, Office 10

ES 28020 Madrid

T +34 911 593 175

Copenhagen

Symbion / Fruebjergvej 3

DK-2100 Copenhagen Ø

T +45 702 810 22